1. Benefits of Advisory Panels Explore unmet needs Identify opportunities Review development plans Review protocols Understand patient needs Network PharmiKom Inc.

2. Cost Direct costs Advisers, Vendors, Venue Indirect costs Company time Hidden costs Success or Failure? PharmiKom Inc.

3. Decision Methods Individual or Directive Consultative Consultative Consensus Modified Consensus Consensus Vote PharmiKom Inc. Modified from Justice and Jamieson 2006

4. Decision Methods Individual Consultative Consultative Consensus Modified Consensus Consensus Voting PharmiKom Inc.

5. Consultative Consensus The chairman of the meeting consults with the group members seeking consensus but always keeps control of the decision PharmiKom Inc.

6. When to use? When chairman has relevant expertise and/or has a high degree of responsibility for the implementation of decisions When there is a desire to be collaborative and participative and not alienate participants When facilitation skills are high in chairman or available through co-chair /neutral facilitator The sponsor chairs the meeting PharmiKom Inc.

7. Disadvantages Time consuming It may be perceived as manipulative Requires a high degree of expertise PharmiKom Inc.

8. Advantages Avoids deadlock trying to reach full consensus Chairman is clearly the leader Participants are more likely to be supportive of decisions that are not their own opinion PharmiKom Inc.

9. Preparation Good preparation is the key to a successful meeting PharmiKom Inc.

10. Preparation Objectives 12 months ahead Agenda 3 to 6 months ahead Select Participants 3 to 6 months ahead PharmiKom Inc.

11. Preparation Consulting Agreement 3 months ahead Questions 2 months ahead Background reading 1 to 2 months ahead Plan Venue 3 to 6 months ahead Confirm Venue 1 to 3 months ahead Finalize Venue 1 month ahead PharmiKom Inc.

12. The Meeting FocusMomentumRecordParticipationRoomControlSummarizeFeedbackListenPresentationTime PharmiKom Inc. Chairman Facilitator

13. Outcome Record/transcription Meeting Report Minutes Executive Summary Follow up Evaluation PharmiKom Inc.

14. Compliance Pharmaceutical Research and Manufacturers of America PharmiKom Inc.

15. Compliance Specific CSA Appropriate advisers Size Record keeping Venue PharmiKom Inc.

16. Compliance Professional Organizations PharmiKom Inc.